0
Key points:
  • Oil and gas prices have fallen slightly due to hopes of Middle East peace talks.
  • The cost of filling a typical diesel tank in the UK has hit £100 according to RAC data.
  • Stock markets showed mixed performance, with US services sector index ticking up but German and French indexes staying flat.
  • Key pharmaceutical companies Eli Lilly and AstraZeneca reported strong financial results despite market uncertainties.

Oil Prices Fall Amid Middle East Peace Hopes

The price of Brent crude oil has dropped by 55 cents, or 0.78%, to $78.75 per barrel on the hopes of a breakthrough in Middle East peace negotiations. While oil prices have been volatile recently, this latest dip was seen as positive for global markets.

UK Economy Reports Positive Service Sector Growth

The UK economy saw some positive movement with service industries returning to growth, according to the latest US services survey from the Institute for Supply Management. The headline measure ticked up to 54.1 in July, indicating expansion in the sector despite tensions resurfacing.

Market Performance Across the Globe

Global Markets Sway as Oil Prices Fall Amid Middle East Peace Talks
Global Markets Sway as Oil Prices Fall Amid Middle East Peace Talks

The Dow Jones on Wall Street rose by 1% while the Nasdaq and S&P 500 indexes increased slightly around 0.3%. The UK’s FTSE 100 index climbed 0.3%, but German, French, and Italian markets stayed flat to lower.

Notable among stock market movers were Prudential, HSBC, and Standard Chartered, which saw a decline on the FTSE 100 after China’s Caixin reported that tax authorities began levying personal income taxes on returns from offshore insurance policies. However, pharmaceutical company Eli Lilly gained more than 5% in US markets following better-than-expected second-quarter results, with strong sales of its weight loss and diabetes drugs.

Key Financial Reports

Eli Lilly announced a significant revenue increase for the second quarter, driving growth outside the United States. The company’s shares jumped as they outpaced Danish rival Novo Nordisk, indicating robust demand for their products despite potential pricing pressures in the US and competition from Novo’s recently launched Wegovy pill.

AstraZeneca saw a rise of more than 4% after reports suggested no discussions with Bristol Myers Squibb about a £300bn merger. This news had previously caused a significant drop in AstraZeneca’s share price, but the company clarified there were never any talks or discussions.

Pharma and Tech Market Dynamics

The pharmaceutical sector saw strong performances from companies like Eli Lilly, while tech giant SpaceX reported robust revenue growth despite hefty capital expenditures. This reflects both the high costs associated with long-term business ambitions and the potential for significant returns in key market segments.

Source: The Guardian


Business Daily

335 posts

Related post